| Dr Kenneth Ward, MD | |
|
110 Commerce Dr, Shelton, CT 06484-6244 | |
| (203) 929-7331 | |
| (203) 925-0330 |
| Full Name | Dr Kenneth Ward |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 110 Commerce Dr, Shelton, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386700201 | NPI | - | NPPES |
| 001235647 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 023564 (Connecticut) | Primary |
| Entity Name | Griffin Faculty Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598755605 PECOS PAC ID: 7618871997 Enrollment ID: O20031120000158 |
News Archive
In this interview, News-Medical speaks to research associate Dr. Alessandra Stangherlin about her latest research that provided new insights into the circadian rhythm of the heart.
Surgically repairing a painful shoulder injury in baseball players known as a SLAP tear (superior labral) varies widely and often doesn't allow for return to play at the same level as before the injury. However, researchers presenting their findings at the American Orthopaedic Society for Sports Medicine's Annual Meeting in Baltimore, Maryland suggest that nonsurgical treatment may be more beneficial.
A groundbreaking tumor-highlighting technology- OTL38- enhances the visualization of lung cancer tissue, providing surgeons with a significantly better chance of finding and removing more cancer than previously possible, according to a scientific presentation at the 56th Annual Meeting of The Society of Thoracic Surgeons.
Gulf War Illness (GWI)-the chronic health condition that affects about one in four military veterans of the 1991 Gulf War-appears to be the result of several factors, which differed in importance depending upon the locations where veterans served during the war, according to a Baylor University study.
Arrowhead Research Corporation, a targeted therapeutics company, today announced that, through its Calando Pharmaceuticals subsidiary, it has completed enrollment of a phase 1b clinical trial of CALAA-01, its RNAi therapeutic candidate targeting solid tumors. All patients participating in the trial have completed dosing with the exception of one patient who is still receiving treatment and will continue to be monitored.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kenneth Ward, MD 67 Maple Ave, Derby, CT 06418-1328 Ph: (203) 732-1330 | Dr Kenneth Ward, MD 110 Commerce Dr, Shelton, CT 06484-6244 Ph: (203) 929-7331 |
News Archive
In this interview, News-Medical speaks to research associate Dr. Alessandra Stangherlin about her latest research that provided new insights into the circadian rhythm of the heart.
Surgically repairing a painful shoulder injury in baseball players known as a SLAP tear (superior labral) varies widely and often doesn't allow for return to play at the same level as before the injury. However, researchers presenting their findings at the American Orthopaedic Society for Sports Medicine's Annual Meeting in Baltimore, Maryland suggest that nonsurgical treatment may be more beneficial.
A groundbreaking tumor-highlighting technology- OTL38- enhances the visualization of lung cancer tissue, providing surgeons with a significantly better chance of finding and removing more cancer than previously possible, according to a scientific presentation at the 56th Annual Meeting of The Society of Thoracic Surgeons.
Gulf War Illness (GWI)-the chronic health condition that affects about one in four military veterans of the 1991 Gulf War-appears to be the result of several factors, which differed in importance depending upon the locations where veterans served during the war, according to a Baylor University study.
Arrowhead Research Corporation, a targeted therapeutics company, today announced that, through its Calando Pharmaceuticals subsidiary, it has completed enrollment of a phase 1b clinical trial of CALAA-01, its RNAi therapeutic candidate targeting solid tumors. All patients participating in the trial have completed dosing with the exception of one patient who is still receiving treatment and will continue to be monitored.
› Verified 4 days ago
Mrs. Brittany Herman, APRN Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 887 Bridgeport Ave, Shelton, CT 06484 Phone: 203-225-6020 | |
Dr. Saroja Koneswaran, MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 21 Huntington Plaza, Shelton, CT 06484 Phone: 203-929-6358 Fax: 203-929-3826 | |
Dr. Elizabeth Arbia, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 110 Commerce Dr, Shelton, CT 06484 Phone: 203-929-7331 Fax: 203-925-0330 | |
Stephanie J Rowe, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 887 Bridgeport Ave, Shelton, CT 06484 Phone: 203-225-6020 Fax: 203-384-3829 | |
Dr. Fadeke O Longe, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 4 Corporate Dr, Shelton, CT 06484 Phone: 203-225-0375 | |
Dr. Bharvi Ashok Balar, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 224 Leavenworth Rd, Shelton, CT 06484 Phone: 203-926-1206 Fax: 203-926-0413 |